✦ LIBER ✦

Two-Year Results of Odanacatib (MK-822) Treatment in Postmenopausal Women with Low Bone Mineral Density

✍ Scribed by McClung, Michael; Eisman, John; Bone, Henry; Roux, Christian; Recker, Robert; Verbruggen, Nadia; Hustad, Carolyn; DaSilva, Carolyn; Kimmel, Donald; Santora, Arthur

Book ID: 123129615
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 12
Category: Article
ISSN: 1094-6950
DOI: 10.1016/j.jocd.2009.03.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two year results in a randomized, double

Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density

✍ J.A. Eisman; R.R. Recker; M. McClung; H. Bone; C. Roux; N. Verbruggen; C.M. Hust 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Odanacatib treatment in postmenopausal w

Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results

✍ M. McClung; J.A. Eisman; H.G. Bone; C. Roux; R.R. Recker; N. Verbruggen; C.M. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: 3-year continued therapy and resolution of effect

✍ D. Hosking⁎; J.A. Eisman; H. Bone; M. McClung; I. Reid; R. Rizzoli; H. Resch; N. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Odanacatib in the Treatment of Postmenop

Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect

✍ Ian Reid; John Eisman; Henry Bone; David Hosking; Michael McClung; Rene Rizzoli; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Odanacatib in the Treatment of Postmenop

Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect

✍ McClung, Michael R.; Eisman, John A.; Bone, Henry G.; Hosking, David J.; Reid, I 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB